Robert G. Croy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert G. Croy has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- John M. Essigmann
Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
5 shared publications - Bogdan I. Fedeles
Massachusetts Institute of Technology
4 shared publications John M. Essigmann
2 shared publicationsA Nicole Dinaut
1 shared publication- Amanda L. Armijo
Massachusetts Institute of Technology Department of Biological Engineering Cambridge, MA 02139
1 shared publication Angela Y. Zhu
1 shared publication
Latest Publications
- Open Access
- 26 June 2026
- Published by Oxford University Press (OUP) in NAR Molecular Medicine
- Vol. 3 (3)
DNA adduct and mutational profiles reveal a threshold of cellular defenses against N -nitrosodimethylamine administered to mice in drinking water
N-Nitrosodimethylamine (NDMA) is classified as an animal and probable human carcinogen. Murine liver DNA adducts, mutations, MGMT and CYP2E1 were evaluated following chronic administration of NDMA in drinking water. In a dose-escalation study, 7-methylguanine (m7G) increased linearly with NDMA dose. O6-Methylguanine (m6G) remained near background for NDMA doses up to ∼1 ppm, beyond which its level, and corresponding mutations, rose steeply. An extended study was done with 5 ppm NDMA, in which adducts were measured at 3 and 10 weeks and mutations at 10 weeks. We found that both sexes experienced elevated levels of point mutations closely tracking with the levels of m6G, which emerged as the dominant mutagenic adduct under chronic dosing with NDMA. Homologous recombination-mediated chromosomal rearrangements, however, did not increase over background. Mutational analysis over 96 trinucleotide contexts revealed predominantly GC→AT mutations in 5′-purine-G-3′ contexts in a pattern matching human COSMIC cancer mutational signature SBS11, with secondary features resembling SBS119 (AT→GC). Moreover, we identified the m6G level (∼2000 adducts/diploid genome) above which its dedicated repair protein, MGMT, became saturated. The coordinated application of DNA adduct, mutational and biochemical analyses provides a new approach for studying mechanisms of carcinogenesis, with relevance to early cancer detection and cancer management.
- 26 June 2026
- Published by Oxford University Press (OUP) in NAR Molecular Medicine
- Vol. 3 (3)
Open AccessDNA adduct and mutational profiles reveal a threshold of cellular defenses against N -nitrosodimethylamine administered to mice in drinking water
N-Nitrosodimethylamine (NDMA) is classified as an animal and probable human carcinogen. Murine liver DNA adducts, mutations, MGMT and CYP2E1 were evaluated following chronic administration of NDMA in drinking water. In a dose-escalation study, 7-methylguanine (m7G) increased linearly with NDMA dose. O6-Methylguanine (m6G) remained near background for NDMA doses up to ∼1 ppm, beyond which its level, and corresponding mutations, rose steeply. An extended study was done with 5 ppm NDMA, in which adducts were measured at 3 and 10 weeks and mutations at 10 weeks. We found that both sexes experienced elevated levels of point mutations closely tracking with the levels of m6G, which emerged as the dominant mutagenic adduct under chronic dosing with NDMA. Homologous recombination-mediated chromosomal rearrangements, however, did not increase over background. Mutational analysis over 96 trinucleotide contexts revealed predominantly GC→AT mutations in 5′-purine-G-3′ contexts in a pattern matching human COSMIC cancer mutational signature SBS11, with secondary features resembling SBS119 (AT→GC). Moreover, we identified the m6G level (∼2000 adducts/diploid genome) above which its dedicated repair protein, MGMT, became saturated. The coordinated application of DNA adduct, mutational and biochemical analyses provides a new approach for studying mechanisms of carcinogenesis, with relevance to early cancer detection and cancer management.
- Open Access
Structurally Similar Mycotoxins Aflatoxin B1 and Sterigmatocystin Trigger Different and Distinctive High-Resolution Mutational Spectra in Mammalian Cells
Aflatoxin B1 (AFB1) and sterigmatocystin (ST) are mycotoxins that pose significant threats to human and animal health owing to their mutagenic, carcinogenic, and toxic properties. They are structurally similar and widely believed to exert their biological effects via the generation of DNA-damaging epoxides at their respective terminal furan rings. Despite structural identity in the warhead portion of each toxin, this work shows that distal parts of each molecule are responsible for the distinctive mutational fingerprints seen in gptΔ C57BL/6J mouse embryo fibroblasts (MEFs). The two toxins differ structurally in the puckered cyclopentenone ring of AFB1 and in the planar xanthone functionality of ST. While both toxins mainly induce GC→TA mutations, the aforementioned differences in structure apparently trigger unique patterns of mutations, as revealed by high-resolution duplex sequencing of MEF genomes. AFB1 is more mutagenic than ST and displays its transversion mutations in a pattern with primary and secondary hotspots (underscored) in 5′-CGC-3′ and 5′-CGG-3′ contexts, respectively. ST displays a modest 5′-CGG-3′ hotspot while its other GC→TA transversions are more uniformly distributed in a pattern resembling established oxidative stress mutational spectra. This research delineates the mutational spectra of AFB1 and ST, establishing these patterns as possible early-onset biomarkers of exposure.
Open AccessStructurally Similar Mycotoxins Aflatoxin B1 and Sterigmatocystin Trigger Different and Distinctive High-Resolution Mutational Spectra in Mammalian Cells
Aflatoxin B1 (AFB1) and sterigmatocystin (ST) are mycotoxins that pose significant threats to human and animal health owing to their mutagenic, carcinogenic, and toxic properties. They are structurally similar and widely believed to exert their biological effects via the generation of DNA-damaging epoxides at their respective terminal furan rings. Despite structural identity in the warhead portion of each toxin, this work shows that distal parts of each molecule are responsible for the distinctive mutational fingerprints seen in gptΔ C57BL/6J mouse embryo fibroblasts (MEFs). The two toxins differ structurally in the puckered cyclopentenone ring of AFB1 and in the planar xanthone functionality of ST. While both toxins mainly induce GC→TA mutations, the aforementioned differences in structure apparently trigger unique patterns of mutations, as revealed by high-resolution duplex sequencing of MEF genomes. AFB1 is more mutagenic than ST and displays its transversion mutations in a pattern with primary and secondary hotspots (underscored) in 5′-CGC-3′ and 5′-CGG-3′ contexts, respectively. ST displays a modest 5′-CGG-3′ hotspot while its other GC→TA transversions are more uniformly distributed in a pattern resembling established oxidative stress mutational spectra. This research delineates the mutational spectra of AFB1 and ST, establishing these patterns as possible early-onset biomarkers of exposure.
- Open Access
- 1 September 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (39) , 33910-33920
Chemical Genetics Analysis of an Aniline Mustard Anticancer Agent Reveals Complex I of the Electron Transport Chain as a Target
- 1 September 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (39) , 33910-33920
Open AccessChemical Genetics Analysis of an Aniline Mustard Anticancer Agent Reveals Complex I of the Electron Transport Chain as a Target
- 1 March 2009
- Published by Defense Technical Information Center (DTIC)
Development of Novel Bifunctional Compounds That Induce Apoptosis in Prostate Cancer Cells
We have designed and synthesized a novel compound (11?) that efficiently triggers apoptosis in prostate cancer cells such as LNCaP. This bifunctional compound was designed to form DNA adducts that are camouflaged by the androgen receptor making them less readily repaired in AR+ prostate cancer cells. The aims of our studies are to investigate the mechanisms by which 11? is able to trigger apoptosis in target cells. Methods have been developed that permit us to determine the fates of 11?-DNA adducts in treated cells in culture as well as in tumors growing in animal models. Another objective is to identify the signaling events that lead from DNA adducts to activation of the apoptotic program. Finally we have obtained encouraging results from animal experiments that indicate that molecules such as 11? may have clinical potential for the treatment of human tumors.
- 1 March 2009
- Published by Defense Technical Information Center (DTIC)
Development of Novel Bifunctional Compounds That Induce Apoptosis in Prostate Cancer Cells
We have designed and synthesized a novel compound (11?) that efficiently triggers apoptosis in prostate cancer cells such as LNCaP. This bifunctional compound was designed to form DNA adducts that are camouflaged by the androgen receptor making them less readily repaired in AR+ prostate cancer cells. The aims of our studies are to investigate the mechanisms by which 11? is able to trigger apoptosis in target cells. Methods have been developed that permit us to determine the fates of 11?-DNA adducts in treated cells in culture as well as in tumors growing in animal models. Another objective is to identify the signaling events that lead from DNA adducts to activation of the apoptotic program. Finally we have obtained encouraging results from animal experiments that indicate that molecules such as 11? may have clinical potential for the treatment of human tumors.
- Open Access
- 1 February 2009
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 103 (2) , 256-261
A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor
- 1 February 2009
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 103 (2) , 256-261
Open AccessA bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor
- Open Access
- 1 March 2008
- Published by Defense Technical Information Center (DTIC)
Development of Novel Bifunctional Compounds that Induce Apoptosis in Prostate Cancer Cells
This study summarizes the air-ground support doctrine and systems employed by both the Allies and their adversaries in World War II. It is intended to identify similarities and differences in the doctrinal and procedural systems employed by the combatants; it is in no sense a complete historical study of air-ground operations during the war. The value of the study lies in its narrow focus on a specific application of air power and in its comparative examination of this application. This approach helps us to understand that, as of 1939, close air support for ground combat forces was a tactic universally discussed by the military powers but not universally accepted and practiced until after the war. At the onset of the war, only the Germans had developed a doctrine and a procedural system for close air support. The Russians and the Japanese had a doctrinal base, but lacked the integrating procedures necessary to convert doctrine into practice. Italy and France had neither doctrine nor procedures for substantive close air support. In the case of the United States and Great Britain, prewar debate and doctrine tended to inhibit development of close air support. Once the war began, battlefield requirements forced change. Despite their different starting points, by war's end all major belligerents employed air-ground systems with some remarkably similar features. However, there were major differences between the U.S. and British systems and the German version. These similarities and differences are described in this paper. The appendix describes current Soviet close air support doctrine.
- 1 March 2008
- Published by Defense Technical Information Center (DTIC)
Open AccessDevelopment of Novel Bifunctional Compounds that Induce Apoptosis in Prostate Cancer Cells
This study summarizes the air-ground support doctrine and systems employed by both the Allies and their adversaries in World War II. It is intended to identify similarities and differences in the doctrinal and procedural systems employed by the combatants; it is in no sense a complete historical study of air-ground operations during the war. The value of the study lies in its narrow focus on a specific application of air power and in its comparative examination of this application. This approach helps us to understand that, as of 1939, close air support for ground combat forces was a tactic universally discussed by the military powers but not universally accepted and practiced until after the war. At the onset of the war, only the Germans had developed a doctrine and a procedural system for close air support. The Russians and the Japanese had a doctrinal base, but lacked the integrating procedures necessary to convert doctrine into practice. Italy and France had neither doctrine nor procedures for substantive close air support. In the case of the United States and Great Britain, prewar debate and doctrine tended to inhibit development of close air support. Once the war began, battlefield requirements forced change. Despite their different starting points, by war's end all major belligerents employed air-ground systems with some remarkably similar features. However, there were major differences between the U.S. and British systems and the German version. These similarities and differences are described in this paper. The appendix describes current Soviet close air support doctrine.
- 1 July 2004
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (14) , 3829-3833
Design, synthesis, and evaluation of estradiol-linked genotoxicants as anti-cancer agents
- 1 July 2004
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (14) , 3829-3833
Design, synthesis, and evaluation of estradiol-linked genotoxicants as anti-cancer agents